Login | Register

Melanin Production Controlled By Molecular Switch, May Allow True Sunless Tanning



Discovery of a molecular switch that turns off the natural process of skin pigmentation may lead to a novel way of protecting the skin – activating the tanning process without exposure to cancer-causing UV radiation. In their report in the journal Genes & Development, researchers from the Massachusetts General Hospital (MGH) Cutaneous Biology Research Center (CBRC) describe how blocking the action of this switch – an enzyme called PDE-4D3 – in the skin of mice led to a significant increase in melanin production.

“The primary goal of inducing melanin production in human skin would be prevention of skin cancer, since all the common forms are known to be associated with UV exposure, ” explains David Fisher, MD, PhD, director of the hospital’s Department of Dermatology and an investigator at the MGH CBRC, who led the study. “Not only would increased melanin directly block UV radiation, but an alternative way to activate the tanning response could help dissuade people from sun tanning or indoor tanning, both of which are known to raise skin cancer risk.”

In 2006 Fisher’s group showed that the metabolic pathway leading to UV-induced pigmentation is controlled by cyclic AMP (cAMP), a molecule known to regulate many important cellular processes by carrying messages from the cell surface to internal target molecules. Using a strain of transgenic mice with red hair and melanocytes in their epidermis – common mice have none of these melanin-producing cells in the outer skin layer – they found that inducing cAMP production in the animals’ skin led to significant pigmentation. But since the drug used in that study cannot penetrate human skin, they needed to investigate an alternative approach.

Because most drugs act by blocking rather than stimulating their target molecules, better defining the pathway leading from UV exposure to melanin production could identify a step limiting melanin expression that, if suppressed, would increase production of the pigment. The strength and duration of the signals carried by cAMP are controlled by PDE enzymes, which break down the molecule after its message is delivered. Detailed analysis of the melanin expression pathway identified PDE-4D3 as the regulator of cAMP activity in melanocytes. The transcription factor activated by cAMP induces production of both melanin and PDE-4D3, and the enzyme in turn modulates the pigmentation process by breaking down cAMP.

The researchers confirmed role of PDE-4D3 in controlling melanin expression by applying several agents that block PDE production to the skin of the transgenic mice with epidermal melanocytes. After five days of treatment, the animals’ skin had darkened significantly, while treatment of control mice with no epidemal melanocytes produced no effect.

“Although PDE enzymes degrade cAMP within all cells, different members of this enzyme family are active in different types of cells,” Fisher explains. “We showed that PDE-4D3 is particularly important within melanocytes, and while the enzyme may have a role in other cells, a blocking drug that is applied directly to the skin would probably have limited effects in other tissues.” Additional research is needed to identify drugs that penetrate human skin and safely block PDE-4D3, he notes, and his team has already starting searching for such agents.

Source:
MedicalNewsToday

, , , ,

One Response to “Melanin Production Controlled By Molecular Switch, May Allow True Sunless Tanning”

  • […] October 16, 2010: Melanin Production Controlled By Molecular Switch, May Allow True Sunless Tanning October 15, 2010: Lay Bystanders Should Do Just Chest Compressions, No Mouth-To-Mouth October 14, 2010: Link Between Vegetable Consumption And Decreased Breast Cancer Risk In African-American Women October 14, 2010: Age-Related Memory Loss In Mice Reversed By Promising Drug Candidate October 12, 2010: Higher Kidney Stone Risk For Postmenopausal Women On Estrogen Therapy October 11, 2010: Common Prostate Cancer Treatment Linked To Bone Decay October 10, 2010: Discovery Could Impact How The Body Receives Medicine October 10, 2010: Thoughts About Time Inspire People To Socialize October 8, 2010: Insoluble Medicines Can Be Made Orally Available If In Nano Crystal October 7, 2010: Hidden In Your Genes There May Be A Thirst For Excitement October 7, 2010: AACN Applauds The New Institute Of Medicine Report Calling For Transformational Change In Nursing Education And Practice October 5, 2010: Human Growth Hormone Shows Promise In Treating Cystic Fibrosis Symptoms October 5, 2010: Researchers Identify First Ever Treatment Effective Against Terminal Cancer In Animals October 1, 2010: 12 Percent Of Workers Would Choose To Quit Or Retire Rather Than Report For Work During A Serious Pandemic […]

Leave a Reply

Your email address will not be published. Required fields are marked *